Avid Bioservices (CDMO:NASDAQ) Investor Relations Material

Overview

Avid Bioservices Inc., a leading contract development and manufacturing organization, is committed to providing top-quality process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services for biopharmaceutical drug substances derived from mammalian cell culture. The company specializes in monoclonal antibodies and recombinant proteins and offers a wide range of services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. Additionally, Avid Bioservices Inc. provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. Its clients are primarily from the biotechnology and biopharmaceutical industries. Founded in 1981 and headquartered in Tustin, California, Avid Bioservices Inc. was formerly known as Peregrine Pharmaceuticals, Inc. and rebranded in January 2018. The company's commitment to providing high-quality biomanufacturing services has continued to place it at the forefront of the industry.

Frequently Asked Questions

What is Avid Bioservices's ticker?

Avid Bioservices's ticker is CDMO

What exchange is Avid Bioservices traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Avid Bioservices's headquarters?

They are based in Tustin, California

How many employees does Avid Bioservices have?

There are 201-500 employees working at Avid Bioservices

What is Avid Bioservices's website?

It is avidbio.com

What type of sector is Avid Bioservices?

Avid Bioservices is in the Healthcare sector

What type of industry is Avid Bioservices?

Avid Bioservices is in the Biotechnology industry

Who are Avid Bioservices's peers and competitors?

The following five companies are Avid Bioservices's industry peers:

- Artelo Biosciences

- Trillium Therapeutics Inc.

- Caladrus Biosciences

- Calithera Biosciences

- Fennec Pharmaceuticals